Non-small cell lung cancer. Subtyping and predictive molecular marker investigations in cytology;Nichtkleinzellige Lungenkarzinome: Subklassifikation und prädiktive molekulare Markeruntersuchungen in der Zytologie

Pathologe

Volumn 33, Issue 4, 2012, Pages 301-307

  Savic, S ^a   Bihl, M P ^a   Bubendorf, L ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

EGFR; EML4 ALK; Non small cell lung cancer; Predictive markers

Indexed keywords

ANTINEOPLASTIC AGENT; EGFR PROTEIN, HUMAN; EML4 ALK FUSION PROTEIN, HUMAN; EML4-ALK FUSION PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN;

ADENOCARCINOMA; ALGORITHM; BIOPSY; CANCER STAGING; CLASSIFICATION; CYTOLOGY; GENETIC MARKER; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ALGORITHMS; ANTINEOPLASTIC AGENTS; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL BIOLOGY; DNA MUTATIONAL ANALYSIS; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; NEOPLASM STAGING; ONCOGENE PROTEINS, FUSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME;

EID: 84864432216     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-012-1577-9     Document Type: Article

References (19)

1. Bubendorf L, Savic S (2009) Predictive EGFR gene analyses in cytology. Pathologe 30(Suppl 2):136-139
2. Camidge DR, Kono SA, Flacco A et al (2010) Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment. Clin Cancer Res 16:5581-5590
3. Johnson DH, Fehrenbacher L, Novotny WF et al (2004) Randomized phase II trial comparing beva-cizumab plus carboplatin and paclitaxel with car-boplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 22:2184-2191 (Pubitemid 41095154)
4. Kwak EL, Bang YH, Camidge DR et al (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363:1693-1703
5. Mcleer-Florin A, Moro-Sibilot D, Melis A et al (2012) Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study. J Thorac Oncol 7:348-354
6. Meyerson M, Gabriel S, Getz G (2010) Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11:685-696
7. Mok TS, Wu YL, Thongprasert S et al (2009) Gefiti-nib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361:947-957
8. Nicholson AG, Gonzalez D, Shah P et al (2010) Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytoke-ratin 5/6, and P63, and EGFR mutation analysis. J Thorac Oncol 5:436-441
9. Pao W, Girard N (2011) New driver mutations in non-small-cell lung cancer. Lancet Oncol 12:175-180
10. Pirker R, Herth FJ, Kerr KM et al (2010) Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol 5:1706-1713
11. Rekhtman N, Brandt SM, Sigel CS et al (2011) Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing. J Thorac Oncol 6:451-458
12. Sasaki T, Rodig SJ, Chirieac LR et al (2010) The biology and treatment of EML4-ALK non-small cell lung cancer. Eur J Cancer 46:1773-1780
13. Savic S,Tapia C, Grilli B et al (2008) Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers. Br J Cancer 98:154-160
14. Scagliotti G, Brodowicz T, Shepherd FA et al (2011) Treatment-by- histology interaction analyses in three phase III trials show superiority of pemetre-xed in nonsquamous non-small cell lung cancer. J Thorac Oncol 6:64-70
15. Sigel CS, Moreira AL, Travis WD et al (2011) Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens. J Thorac Oncol 6:1849-1856
16. Soda M, Choi YL, Enomoto M et al (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448:561-566 (Pubitemid 47206930)
17. Travis WD, Brambilla E, Noguchi M et al (2011) International association for the study of lung can-cer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244-285
18. Wu M, Szporn AH, Zhang D et al (2005) Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. Diagn Cyto-pathol 33:223-227 (Pubitemid 41368249)
19. Zusman-Harach SB, Harach HR, Gibbs AR (1991) Cytological features of non-small cell carcinomas of the lung in fine needle aspirates. J Clin Pathol 44:997-1002